Business & regional news

Month Year

Email alerts

Mar 1, 2024

Medtronic receives FDA clearance for OsteoCool™ 2.0 bone tumor ablation system

Doubled probe count enables multi-level spine tumor ablations for increased flexibility and efficiency Medtronic plc, a global leader in healthcare technology, today announced that it has received...
- Neuromodulation
Jan 18, 2024

Medtronic highlights new clinical data demonstrating benefits of spinal cord stimulation in two late-breaking presentations at the North American Neuromodulation Society (NANS) Annual Meeting 2024

86% of subjects preferred closed-loop SCS in a multicenter, randomized, crossover, single blind study of Medtronic’s investigational closed-loop SCS system at one month

24-month European RCT data demonstrates long-term superiority of DTM™ SCS compared with conventional medical management (CMM) for indicated chronic back pain patients not eligible for spine surgery
- Neuromodulation
Nov 10, 2023

Medtronic announces 12-month study results showing DTM™ spinal cord stimulation programming provides long-term, significant pain relief for indicated chronic back pain patients not eligible for spine surgery

NOVA Study: On-label, prospective, multicenter, randomized controlled trial compared DTM™ SCS to conventional spinal cord stimulation
- Neuromodulation
Oct 4, 2023

Medtronic names Paolo Di Vincenzo president of the Neuromodulation business
- Neuromodulation
Jan 13, 2023

Medtronic enables a commitment to collaboration in continence care between international scientific societies and patient organizations

Show per page

Su	Mo	Tu	We	Th	Fr	Sa

Su	Mo	Tu	We	Th	Fr	Sa